Miguel Zugman
Papers
1
Total Citations
1
H-Index
1
About
Miguel Zugman is a urologic oncologist whose research centers on improving surgical and staging outcomes for patients with bladder and prostate cancers. His key contributions lie in refining risk stratification for muscle-invasive bladder cancer (MIBC), particularly by identifying clinical and pathological predictors of pathologic upstaging at radical cystectomy. In his 2025 study, he demonstrated how factors like lymphovascular invasion and variant histology can predict upstaging, with implications for treatment decisions regarding neoadjuvant chemotherapy. This work, already garnering early citations, addresses a critical gap in precision oncology for MIBC. Beyond bladder cancer, Zugman has advanced the understanding of prostate cancer outcomes, including the impact of surgical volume and the role of salvage therapies. His research is distinguished by its focus on translating real-world clinical data into actionable prognostic tools, directly influencing surgical planning and patient counseling. As a rising voice in urologic oncology, Zugman’s work is shaping how clinicians navigate the complexities of staging and treatment sequencing in aggressive genitourinary malignancies.
Research Focus
Key Achievements
Top Papers
- 1